Inflammation-induced foam cell formation in chronic inflammatory disease

Immunology and Cell Biology
Thomas A AngelovichAnthony Jaworowski

Abstract

Atherosclerosis is the leading cause of cardiovascular disease and is both a metabolic and inflammatory disease. Two models describe early events initiating atherosclerotic plaque formation, whereby foam cells form in response to hyperlipidaemia or inflammation-associated stimuli. Although these models are inextricably linked and not mutually exclusive, identifying the unique contribution of each in different disease settings remains an important question. Circulating monocytes are key mediators of atherogenesis in both models as precursors to lipid-laden foam cells formed in response to either excess lipid deposition in arteries, signalling via pattern-associated molecular patterns or a combination of the two. In this review, we assess the role of monocytes in each model and discuss how key steps in atherogenesis may be targeted to enhance clinical outcomes in patients with chronic inflammatory disease.

References

May 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·K J Williams, I Tabas
Dec 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·G RotheG Schmitz
May 29, 1998·Circulation·P W WilsonW B Kannel
Dec 10, 1999·Journal of the American College of Cardiology·C J WiedermannJ Willeit
Aug 10, 2000·Clinical and Experimental Immunology·H BruunsgaardB K Pedersen
Jul 19, 2002·The New England Journal of Medicine·Stefan KiechlDavid A Schwartz
Aug 28, 2002·Circulation·Gertrud U SchusterJan-Ake Gustafsson
Jan 14, 2003·Nature Medicine·Sean B JosephPeter Tontonoz
Mar 12, 2003·Circulation·Daniel H SolomonGary C Curhan
Jun 12, 2003·JAMA : the Journal of the American Medical Association·Sharon A RiddlerLawrence A Kingsley
Aug 19, 2003·Atherosclerosis·Lars Lind
Dec 19, 2003·The New England Journal of Medicine·Mary J RomanJane E Salmon
Jul 14, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kathrin S MichelsenMoshe Arditi
Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jaime LlodráGwendalyn J Randolph
Jan 22, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Emil V KozarovAnn Progulske-Fox
Feb 19, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Yury I MillerJoseph L Witztum
Feb 24, 2005·Journal of Atherosclerosis and Thrombosis·Kazuhiro AshidaFumitaka Ohsuzu
Mar 8, 2005·Arthritis and Rheumatism·Hilal Maradit-KremersSherine E Gabriel
Jul 15, 2006·Journal of Lipid Research·Mathijs GroenewegMenno P J de Winther
Nov 2, 2006·PLoS Biology·Zahedi MujawarDmitri Sviridov
Nov 7, 2006·Cell Metabolism·Jochen G SchneiderClay F Semenkovich
Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Jan 4, 2007·The Journal of Clinical Investigation·Filip K SwirskiMikael J Pittet
Apr 26, 2007·The Journal of Clinical Endocrinology and Metabolism·Virginia A TriantSteven K Grinspoon
Nov 23, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Clarisse Cuaz-PérolinMustapha Rouis
Feb 8, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Cheuk-Chun SzetoPhilip Kam-Tao Li

❮ Previous
Next ❯

Citations

Jun 27, 2015·International Journal of Molecular Sciences·Kexin SunYonghua Hu
Mar 26, 2016·Trends in Cardiovascular Medicine·Saheli SamantaJohnson Rajasingh
Jun 22, 2016·Nature Communications·Jérémie GautheronTom Luedde
Feb 2, 2017·International Journal of Molecular Sciences·Barbara RizzacasaFrancesca Amati
Aug 31, 2018·PLoS Pathogens·Valentina GuerriniMaria Laura Gennaro
Jan 19, 2018·Scientific Reports·Samuel R SmithJim Sun
Nov 10, 2018·Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry·Nittaya ChansiwSomdet Srichairatanakool
May 15, 2018·Nutrients·Alexandros TsouprasIoannis Zabetakis
Aug 12, 2016·Clinical Science·Kelvin H M KwokKaren S L Lam
Jul 5, 2018·Current Hypertension Reports·Michalina LisowskaAgata Sakowicz
Jun 13, 2019·International Journal of Hypertension·Daniela Maria TanaseMariana Floria
Feb 22, 2017·Frontiers in Pharmacology·Feng XueYan-Dong Wang
Jan 4, 2021·Molecular and Cellular Biochemistry·Samira Tabaei, Seyyedeh Samaneh Tabaee
Jan 13, 2021·Experimental and Molecular Pathology·Ariel KartenLora J Kasselman
Jul 8, 2016·Journal of Cardiovascular Pharmacology·Anandita BasuRupak Mukhopadhyay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Related Papers

Current Opinion in Lipidology
Candice M Thomas, Eric J Smart
Archives of Medical Research
Luis Chávez-SánchezFrancisco Blanco-Favela
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
Jacques AmarBernard Chamontin
© 2022 Meta ULC. All rights reserved